CLIN-r+ are delighted to announce their participation at the 6TH ANNUAL BIOCOMPATIBILITY, TOXICOLOGY, EXTRACTABLES & LEACHABLES SUMMIT & EXHIBITION. Our Director of Clinical and Regulatory Affairs, Jacqueline van Druten will be discussing Top 10 Auditor findings in Biocompatibility Evaluation Files for Gas Pathways: How to Overcome Them and comply with the 2024 updates.

CLIN-r+ are delighted to announce their participation at the 2nd Annual Biocompatibility Testing In Medical Devices 2025 Conference! Our Director of Clinical and Regulatory Affairs, Jacqueline van Druten will be discussing Biocompatibility Evaluations for Gas Pathways: Insights into 2024 ISO 18562-Series Updates.

Systematic literature reviews are required by regulatory agencies prove the safety and performance of medical devices, and separate reviews must be conducted at every stage of the device life cycle, including pre-market research, development, device certification, post-market surveillance.

Our Director of Clinical and Regulatory Affairs, Jacqueline van Druten will be discussing the Ace your submission – Focus on EU MDR Clinical Evaluation Conformity routes. What you need to know for your legacy and new products: Day 2 – 15:35 – 16:00 Ace your submission – Focus on EU MDR Clinical Evaluation Conformity routes.…

CLIN-r+ are delighted to announce their participation at the RESCON EUROPE 2024 supporting planning of sustainable MedTech. CLIN-r+ are looking forward to seeing you there! Our Director of Clinical and Regulatory Affairs, Jacqueline van Druten will be supporting the Sustainability discussions on Respiratory MedTech

CLIN-r+ are delighted to announce their participation at the SurgiTech 2024 summit on supporting innovation across the surgical pathway and are looking forward to seeing you there!

Common mistakes in the MedTech sector can delay market entry and reduce company value. Our expert panel will explore these pitfalls, offering insights to keep you ahead. By avoiding these blunders, start-ups can maximise investments, speed up market entry, and enhance their valuation.

The Clinical/Performance Evaluation Report (CER/PER) holds pivotal importance within the context of EU MDR/IVDR applications, determining manufacturers’ eligibility for obtaining the CE mark. Embedded within the Clinical/Performance Evaluation procedure, the systematic literature review (SLR) process emerges as a vital workflow demanding proficiency

As part of MEDICA CLIN-r+ has complimentary EU MDR and UKCA consultation sessions

CLIN-r+ are delighted to announce their participation at the 48th Arab Health Congress 2023, The World Forum for Medicine, and are looking forward to your visit!

The importance of a Medical Device’s intended purpose is often overlooked by marketers as it is not discussed on a daily basis unless you’re involved in its creation and ongoing development.

We are pleased to announce that we will be supporting the ‘The Mastering Clinical and Technology Trials in MedTech’ hosted by the University Of Portsmouth SIGHT Program And NIHR Surgical MedTech Co-Operative.